Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS)
CNY10.60
+0.17 (+1.63%)
CN SHH Basic Materials Chemicals
Address
No.18, Huagong Road 324302
Quzhou, CN
Quzhou, CN
CEO
Deshui Chen
Website
huakangpharma.com
IPO
2021-02-09
ISIN CNE100005477
Description
Zhejiang Huakang Pharmaceutical Co., Ltd. is an international company that focuses on the investigation, manufacturing, and worldwide sale of polyols. Its extensive product range includes xylitol, a polyol with a sweetness level comparable to sugar. Other significant offerings are sorbitol, a white crystalline sugar alcohol, and maltitol, another variety of sugar alcohol. The company also produces xylose, an essential ingredient for making xylitol, and L-arabinos, which can function as a sugar substitute or various additives. The firm's operations are based in Kaihua County, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY10.60
+0.17 (+1.63%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
13M
Beta
0.72
Float Shares
120.20M
Free Float %
40.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.45% | -1.18% | +3.23% | +4.76% | +9.87% | +19.01% | +8.58% | -13.22% | -35.00% | -39.72% | -39.72% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
10.60
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.68
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals: +4.0%+49.2% ★ Q1'26: +45.3% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-7.0% Q1'26: -66.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+0.1% Q1'26: -17.6% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+7.8% ★ Q1'26: +4.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.2% ★ Q1'26: +2.9% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-19.7% ★ Q1'26: -19.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×4.55× Q1'26: 18.69× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
1.59B
est: 1.43B (+11.6%)
|
2.20B
est: 1.57B (+39.8%)
|
2.78B
est: 2.66B (+4.6%)
|
2.81B
est: 2.95B (-4.6%)
|
4.19B
est: 4.22B (-0.6%)
|
5.27B
5.27B – 5.27B
+25.0% YoY
|
6.59B
6.59B – 6.59B
+25.1% YoY
|
8.08B
8.08B – 8.08B
+22.5% YoY
|
| EBITDA |
342.37M
est: 333.29M (+2.7%)
|
463.16M
est: 367.38M (+26.1%)
|
633.26M
est: 620.86M (+2.0%)
|
520.38M
est: 580.80M (-10.4%)
|
619.56M
est: 831.46M (-25.5%)
|
1.04B
1.04B – 1.04B
+25.0% YoY
|
1.30B
1.30B – 1.30B
+25.1% YoY
|
1.59B
1.59B – 1.59B
+22.5% YoY
|
| EBIT |
257.97M
est: 248.49M (+3.8%)
|
357.71M
est: 273.90M (+30.6%)
|
460.41M
est: 462.88M (-0.5%)
|
321.08M
est: 401.90M (-20.1%)
|
327.29M
est: 575.36M (-43.1%)
|
719.33M
719.33M – 719.33M
+25.0% YoY
|
899.61M
899.61M – 899.61M
+25.1% YoY
|
1.10B
1.10B – 1.10B
+22.5% YoY
|
| Net Income |
236.71M
est: 405.16M (-41.6%)
|
319.28M
est: 479.36M (-33.4%)
|
371.45M
est: 468.32M (-20.7%)
|
268.48M
est: 254.93M (+5.3%)
|
200.30M
est: 254.93M (-21.4%)
|
282.24M
282.24M – 282.24M
+10.7% YoY
|
421.84M
421.84M – 421.84M
+49.5% YoY
|
552.34M
552.34M – 552.34M
+30.9% YoY
|
| SGA |
80.71M
est: 36.60M (+120.5%)
|
106.63M
est: 40.34M (+164.3%)
|
127.68M
est: 68.17M (+87.3%)
|
186.10M
est: 133.89M (+39.0%)
|
67.31M
est: 191.67M (-64.9%)
|
239.63M
239.63M – 239.63M
+25.0% YoY
|
299.69M
299.69M – 299.69M
+25.1% YoY
|
367.16M
367.16M – 367.16M
+22.5% YoY
|
| EPS |
0.82
est: 1.07 (-23.5%)
|
1.08
est: 1.27 (-14.8%)
|
1.25
est: 1.24 (+0.9%)
|
0.90
est: 0.84 (+7.1%)
|
0.66
est: 0.84 (-21.4%)
|
0.93
0.93 – 0.93
+10.7% YoY
|
1.39
1.39 – 1.39
+49.5% YoY
|
1.82
1.82 – 1.82
+30.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-13 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
674.58M
OE per share TTM
2.26
Owner's Yield
12.85%
Maintenance CapEx ratio
486.92%
Maint CapEx / Avg PPE
78.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 5 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 26.7K | 0.46% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 73.0K | 0.39% |
| 3 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 4.2K | 0.44% |
| 4 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 51.8K | 0.28% |
| 5 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 37.6K | 0.29% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
242.4K
Shares Outstanding
298.44M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Deshui Chen | Chairman of the Board & GM | — | male |
| Jiafa Wang | Financial Director | — | male |
| Xiaoyang Zheng | Deputy GM & Director | — | male |
| Xinping Cheng | Executive Deputy GM & Director | — | male |
| Zhiping Wu | Secretary | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 605077.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
